Search Results

FILTER BY

1 - 12 of 634 matches

Sort by:
  • NewsConference NewsEuroPCR 2025

    Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

    L.A. McKeown

    May 30, 2025

  • NewsConference NewsCX Symposium 2025

    Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

    L.A. McKeown

    April 24, 2025

  • NewsDaily News

    Top Endovascular News of 2024

    L.A. McKeown

    December 28, 2024

  • NewsConference NewsVIVA 2024

    Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

    L.A. McKeown

    November 5, 2024

  • PresentationTCT 2024

    Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

    Presenter:  

    Lei Song

    October 30, 2024

  • PresentationTCT 2024

    TCT 1101: Management of Broken and Migrated Bioresorbable Coronary Scafold

    Presenter:  

    Thair Khuziem

    October 30, 2024

  • PresentationTCT 2024

    Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

    Presenter:  

    Sahil Parikh

    October 30, 2024

  • PresentationTCT 2024

    Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

    Presenter:  

    Grzegorz Kaluza

    October 30, 2024

  • PresentationTCT 2024

    TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

    Presenter:  

    Han Chen

    October 29, 2024

  • PresentationTCT 2024

    TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

    Presenter:  

    Shoichi Kuramitsu

    October 29, 2024

  • PresentationTCT 2024

    TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

    Presenter:  

    Marta Mazur

    October 29, 2024

  • PresentationTCT 2024

    TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

    Presenter:  

    Matthias Lutz

    October 29, 2024